Lung cancer surgery may be possible for squamous cell carcinoma in the early stages. It may be considered in combination with ...

Most lung cancers are called non-small cell lung cancer (NSCLC). This group includes: adenocarcinoma squamous cell carcinoma large cell carcinoma ALK-positive lung cancer The second, smaller ...

If you have advanced or stage IV NSCLC with EGFR-positive ... FDA Approved for Advanced Squamous Non–Small-Cell Lung Cancer.” Translational Lung Cancer Research: “Treatment of uncommon ...

LUNGevity Foundation and Rising Tide Foundation for Clinical Cancer Research are proud to support Abhijit Patel, MD, PhD, Yale University School of Medicine, with the 2024 Rising Tide Foundation for ...

Significant disparities in the rates of lung cancer diagnoses across different socioeconomic and ethnic groups in England ...

November is Lung Cancer Awareness Month, and early detection is in the air. According to the Centers for Disease Control, ...

The coveted designation for GSK5764227 (GSK'227, previously known as HS-20093) is for the use of the ADC to treat relapsed or refractory extensive-stage small-cell lung ... cancer, as well as ...

Media ReleaseMature data in patients with a minimum follow-up of 22 months (N=21) shows excellent results, well above historical controls and ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Squamous cell lung cancer is typically diagnosed at late stages. It has a high mortality rate and few treatment advances in recent years. But if we can stage-shift the diagnosis of squamous cell ...